Cognition Therapeutics Inc (NASDAQ: CGTX) on Tuesday, plunged -5.36% from the previous trading day, before settling in for the closing price of $1.68. Within the past 52 weeks, CGTX’s price has moved between $0.22 and $3.83.
Healthcare Sector giant saw their annual sales slid by -16.44% over the last five years. The company achieved an average annual earnings per share of 53.20%. With a float of $70.92 million, this company’s outstanding shares have now reached $88.22 million.
The firm has a total of 28 workers. Let’s measure their productivity.
Cognition Therapeutics Inc (CGTX) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Cognition Therapeutics Inc is 19.61%, while institutional ownership is 9.05%. The most recent insider transaction that took place on Jan 31 ’25, was worth 30,001. In this transaction CEO & President of this company bought 38,851 shares at a rate of $0.77, taking the stock ownership to the 38,851 shares.
Cognition Therapeutics Inc (CGTX) Earnings and Forecasts
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.25 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.21) by -0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.08 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 53.20% per share during the next fiscal year.
Cognition Therapeutics Inc (NASDAQ: CGTX) Trading Performance Indicators
Cognition Therapeutics Inc (CGTX) is currently performing well based on its current performance indicators. A quick ratio of 1.54 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.66, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.28 in one year’s time.
Technical Analysis of Cognition Therapeutics Inc (CGTX)
Analysing the last 5-days average volume posted by the [Cognition Therapeutics Inc, CGTX], we can find that recorded value of 1.16 million was lower than the volume posted last year of 4.52 million. As of the previous 9 days, the stock’s Stochastic %D was 20.25%.
During the past 100 days, Cognition Therapeutics Inc’s (CGTX) raw stochastic average was set at 37.43%, which indicates a significant increase from 4.17% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1545 in the past 14 days, which was lower than the 0.1765 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.9145, while its 200-day Moving Average is $0.8652. Now, the first resistance to watch is $1.6700. This is followed by the second major resistance level at $1.7500. The third major resistance level sits at $1.8000. If the price goes on to break the first support level at $1.5400, it is likely to go to the next support level at $1.4900. Should the price break the second support level, the third support level stands at $1.4100.
Cognition Therapeutics Inc (NASDAQ: CGTX) Key Stats
Market capitalization of the company is 140.28 million based on 73,524K outstanding shares. Right now, sales total 0 K and income totals -33,970 K. The company made 0 K in profit during its latest quarter, and -6,730 K in sales during its previous quarter.
